by MM360 Staff | Apr 29, 2025 | Uncategorized
Source: CureToday articles A chance meeting with my childhood friend reminded me — and others— that living with cancer means taking things one day at a time. Read More
by MM360 Staff | Apr 29, 2025 | Uncategorized
Source: CureToday articles The FDA has granted approval to treatment with Tepylute, a ready-to-dilute version of thiotepa, at 100 mg for breast and ovarian cancers. Read More
by MM360 Staff | Apr 29, 2025 | Uncategorized
Source: CureToday articles INX-315, a CDK2 inhibitor, received FDA fast track designation for patients with CCNE1-amplified platinum-resistant ovarian cancer. Read More
by MM360 Staff | Apr 29, 2025 | Uncategorized
Source: CureToday articles SIRT with 90Y resin microspheres led to durable disease control in patients with gastrointestinal stromal tumor liver metastases resistant to TKI therapy. Read More
by MM360 Staff | Apr 28, 2025 | Uncategorized
Source: CureToday articles Alternating between Glivec and Stivarga therapy didn’t impact survival outcomes; it led to more toxicity and discontinuations in patients with GIST. Read More
by MM360 Staff | Apr 28, 2025 | Uncategorized
Source: CureToday articles Breast MRI helps doctors detect disease in newly diagnosed and high-risk patients without replacing mammograms, according to an expert. Read More
